What is autoimmune epilepsy

What is autoimmune epilepsy? How does epilepsy affect the immune system? It is important to clarify the difference between paraneoplastic and autoimmune epilepsy. Recent research suggests that people with autoimmune disease are almost four times likelier to have epilepsy than are people without autoimmune disorders.

Learn about the characteristics that might indicate autoimmune epilepsy and which tests can be used to confirm the diagnosis. Clinicians caring for patients with either autoimmune disorder or epilepsy should be aware of the strong association between them.

A recent population-level study, investigating the relationship between epilepsy and several common autoimmune diseases, examined a total of 510individuals (). AE often begins with seizures developing over days to weeks. People with cancer, a history of another autoimmune disease, or a parent, sibling or child with an autoimmune disease may be more likely to develop autoimmune epilepsy. She said it could be autoimmune epilepsy , especially knowing my history of other autoimmune issues, namely hypothyroid and autoimmune gastritis.

She said if it was in fact autoimmune epilepsy the good news was that it was treatable, possibly even curable. Up to of new focal-onset epilepsy in adults may have an autoimmune cause. But narrowing down the population of these patients to those most suitable for costly autoantibody testing has been a diagnostic challenge. And “a nonselective approach to testing epilepsy patients for neural autoantibodies is ill advise” Jeffrey W.

Britton, M cautioned during a presentation at the. A link between autoimmunity and epilepsy has been substantiated by large epidemiologic studies, but the nature of the causality requires more research. Epilepsy may present as a symptom of many neurological disorders and often an aetiological explanation cannot be identified. Paraneoplastic limbic encephalitis and NMDA receptor and LGI1. There is growing evidence that autoimmune mechanisms might have a role in some patients.

This includes numerous reports of the detection of theoretically relevant serum autoantibodies, experimental data showing that antibodies can be epileptogenic, and a response of some. Dr Steriade: In our study, we looked at patients with autoimmune epilepsy due to multiple types of antibodies. We identified four patients who had Maantibodies, targeting an intracellular. Until now, treatment has been based mostly on case reports and expert opinion. Epilepsy is a debilitating condition, often with neither a known etiology nor an effective treatment.

The study also found that the risk for epilepsy and autoimmune disease may increase with younger age, though further studies are needed. Besides, recent studies show that epilepsy and autoimmune disease frequently co-occur. To conclude, autoimmune epilepsy is rare in the whole epilepsy population unless features of Table are considered. Autoimmune epilepsy , causes , managment, cure. In anti-NMDAR encephalitis, monosymptomatic cases account for only percent in the largest available series (“seizures only” being just a part of this fraction).

Even if one concedes some sampling bias in favor of more. A considerable proportion of patients with epilepsy of unknown etiology have been demonstrated to have an autoimmune cause.

CLINICAL REFERENCES FOR AUTOIMMUNE EPILEPSY - Quek AM, Britton JW, McKeon A, et al. Toledano M, Britton JW, McKeon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. It is frequently implied that any disorder with seizures and autoantibodies is autoimmune epilepsy (1– 130).

Consequently, most autoimmune encephalitides are routinely categorized as autoimmune epilepsy irrespective of the disease provoking the seizures, type of antibody, or definition of epilepsy (12 131). When autoimmune epilepsy is suspecte first‐line immune therapy with corticosteroids in addition to intravenous immunoglobulin or plasma exchange should be considered. Second‐line therapy with rituximab or cyclophosphamide can be considered if the syndrome is severe.

A response to immune therapy supports the diagnosis of autoimmune epilepsy.